首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Tumor Necrosis Factor Receptor-associated Factor-6 and Ribosomal S6 Kinase Intracellular Pathways Link the Angiotensin II AT1 Receptor to the Phosphorylation and Activation of the IκB Kinase Complex in Vascular Smooth Muscle Cells
【2h】

Tumor Necrosis Factor Receptor-associated Factor-6 and Ribosomal S6 Kinase Intracellular Pathways Link the Angiotensin II AT1 Receptor to the Phosphorylation and Activation of the IκB Kinase Complex in Vascular Smooth Muscle Cells

机译:肿瘤坏死因子受体相关因子6和核糖体S6激酶的细胞内通路将血管紧张素II AT1受体磷酸化并激活血管平滑肌细胞中IκB激酶复合物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Activation of NF-κB transcription factors by locally produced angiotensin II (Ang II) is proposed to be involved in chronic inflammatory reactions leading to atherosclerosis development. However, a clear understanding of the signaling cascades coupling the Ang II AT1 receptors to the activation of NF-κB transcription factors is still lacking. Using primary cultured aortic vascular smooth muscle cells, we show that activation of the IKK complex and NF-κB transcription factors by Ang II is regulated by phosphorylation of the catalytic subunit IKKβ on serine residues 177 and 181 in the activation T-loop. The use of pharmacological inhibitors against conventional protein kinases C (PKCs), mitogen-activated/extracellular signal-regulated kinase (MEK) 1/2, ribosomal S6 kinase (RSK), and silencing RNA technology targeting PKCα, IKKβ subunit, tumor growth factor β-activating kinase-1 (TAK1), the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor-6 (TRAF6), and RSK isoforms, demonstrates the requirement of two distinct signaling pathway for the phosphorylation of IKKβ and the activation of the IKK complex by Ang II. Rapid phosphorylation of IKKβ requires a second messenger-dependent pathway composed of PKCα-TRAF6-TAK1, whereas sustained phosphorylation and activation of IKKβ requires the MEK1/2-ERK1/2-RSK pathway. Importantly, simultaneously targeting components of these two pathways completely blunts the phosphorylation of IKKβ and the proinflammatory effect of the octapeptide. This is the first report demonstrating activation of TAK1 by the AT1R. We propose a model whereby TRAF6-TAK1 and ERK-RSK intracellular pathways independently and sequentially converge to the T-loop phosphorylation for full activation of IKKβ, which is an essential step in the proinflammatory activity of Ang II.
机译:NF-κB转录因子通过局部产生的血管紧张素II(Ang II)的激活被认为与导致动脉粥样硬化发展的慢性炎症反应有关。但是,仍然缺乏对将Ang II AT1受体与NF-κB转录因子激活结合的信号级联的清晰理解。使用原代培养的主动脉血管平滑肌细胞,我们显示Ang II激活IKK复合物和NF-κB转录因子受激活T环中丝氨酸残基177和181上催化亚基IKKβ磷酸化的调节。使用针对常规蛋白激酶C(PKC),促分裂原活化/细胞外信号调节激酶(MEK)1/2,核糖体S6激酶(RSK)的药理抑制剂和针对PKCα,IKKβ亚基,肿瘤生长因子的沉默RNA技术β活化激酶-1(TAK1),E3泛素连接酶肿瘤坏死因子受体相关因子6(TRAF6)和RSK亚型,证明了IKKβ磷酸化和IKK活化需要两个不同的信号通路Ang II的复合体。 IKKβ的快速磷酸化需要由PKCα-TRAF6-TAK1组成的第二个信使依赖性途径,而IKKβ的持续磷酸化和激活则需要MEK1 / 2-ERK1 / 2-RSK途径。重要的是,同时靶向这两个途径的成分会完全钝化IKKβ的磷酸化和八肽的促炎作用。这是第一个证明AT1R激活TAK1的报告。我们提出了一个模型,其中TRAF6-TAK1和ERK-RSK细胞内途径独立且依次收敛于T环磷酸化,从而完全激活IKKβ,这是Ang II促炎活性的重要步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号